Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer

Published:1993-01 Issue:4 Volume:29 Page:518-519
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Planting A.S.T.,Stoter G.,Verweij J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference6 articles.

1. Characterization of the antitumour activity of hexadecylphosphocholine (D 18506);Hilgard;Eur J Cancer Clin Oncol,1988

2. Hexadecylphosphocholine: a new and selective antitumor drug;Eibl;Cancer Treatment Reviews,1990

3. Phase I study of weekly oral miltefosine (hexadecylphosphocholine) in cancer patients;Danhauser,1991

4. WHO Handbook for reporting results of cancer treatment,1979

5. Leuco- and thrombocytosis induced by the ether lipid hexadecylphosphocholine (HePC);Verweij,1991

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Protocol for the Synthesis of 1,2,4-Oxadiazoles Active against Trypanosomatids and Drug-Resistant Leukemia Cell Lines;Tropical Medicine and Infectious Disease;2022-11-28

2. Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection;Experimental Parasitology;2022-05

3. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes;Biochimica et Biophysica Acta (BBA) - Biomembranes;2021-11

4. Lipid raft‐disrupting miltefosine preferentially induces the death of colorectal cancer stem‐like cells;Clinical and Translational Medicine;2021-11

5. Improving the miltefosine efficacy against leishmaniasis by using different nanoassemblies made from surfactants or amphiphilic antimony (V) complex;Applications of Nanobiotechnology for Neglected Tropical Diseases;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3